Showing 101 - 120 results of 326 for search 'Drugs in the United States', query time: 0.08s Refine Results
  1. 101
  2. 102

    Foundational contributions of Svetlana Mojsov to the GLP-1 field by George Barany, Michael J. Barany

    Published 2024-10-01
    “…Despite being the first author on critical formative publications for the field, and being acknowledged, along with Joel Habener, as one of two co-inventors on the controlling United States patents, Mojsov’s foundational contributions were initially overlooked when GLP-1 biochemistry began to be the subject of major scientific prizes. …”
    Get full text
    Article
  3. 103

    A European Approach to Irritable Bowel Syndrome Management by Michel Delvaux, Jacques Frexinos

    Published 1999-01-01
    “…Therefore, following a complete and detailed review published in 1989, these drugs have not been used extensively in the United Kingdom or the United States. …”
    Get full text
    Article
  4. 104
  5. 105
  6. 106
  7. 107

    Human Malaria by C. Roxanne Rutledge-Connelly, Richard H. Baker, C. D. Morris, Jai K. Nayar

    Published 2005-07-01
    “…In the United States and elsewhere, malaria was eradicated by draining larval habitats, treating patients with antimalarial drugs, applying mosquito larvicides and adulticides, and screening doors and windows. …”
    Get full text
    Article
  8. 108

    Human Malaria by C. Roxanne Rutledge-Connelly, Richard H. Baker, C. D. Morris, Jai K. Nayar

    Published 2005-07-01
    “…In the United States and elsewhere, malaria was eradicated by draining larval habitats, treating patients with antimalarial drugs, applying mosquito larvicides and adulticides, and screening doors and windows. …”
    Get full text
    Article
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113

    Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives by Osama A. Khairoalsindi, Ahmad R. Abuzinadah

    Published 2018-01-01
    “…The disease has a poor prognosis, with only two disease-modifying drugs approved by the United States Food and Drug Administration (FDA). …”
    Get full text
    Article
  14. 114

    Progress in Managing Heart Failure: an in-depth Review of Sacubitril/Valsartan Combination Therapy by Neeraj Hiremath, Jayasheela S. Hiremath, Sanatkumar B. Nyamagoud, Agadi Hiremath Viswanatha Swamy

    Published 2024-04-01
    “…Sacubitril/valsartan, an emerging angiotensin receptor-neprilysin inhibitor (ARNI) known for its superior efficacy to conventional treatments, has revolutionized the management of heart failure. The United States Food and Drug Administration has approved the drug’s use in treating patients with chronic heart failure with reduced ejection fraction (HFrEF). …”
    Get full text
    Article
  15. 115

    Antineoplastic Effects of 5-Aminosalicylates and Potential Cancer Preventive Role in Inflammatory Bowel Disease by Hugh J Freeman

    Published 2004-01-01
    “…Early studies from tertiary referral centers in the United States and Europe showed that patients with long-standing and extensive inflammatory bowel disease (IBD) have an increased risk of colon cancer. …”
    Get full text
    Article
  16. 116

    Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer’s Disease: A Comprehensive Review by Hannah W Haddad, Garett W. Malone, Nicholas J. Comardelle, Arielle E. Degueure, Adam M. Kaye, Alan D. Kaye

    Published 2022-01-01
    “…This debilitating disease reportedly consumes 8% of the total United States healthcare expenditure, with medical and nursing outlays accounting for an estimated $290 billion. …”
    Get full text
    Article
  17. 117

    Simulating a travel-related origin of Candida auris in New York–New Jersey by Rita R. Verma, Edward Kiegle, Alexander C. Keyel, Sudha Chaturvedi, Vishnu Chaturvedi

    Published 2025-02-01
    “…ABSTRACT Candida auris first appeared in the United States in 2013 in New York–New Jersey (NY-NJ) and led to an unprecedented outbreak since 2016. …”
    Get full text
    Article
  18. 118
  19. 119

    Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting by Dimitri Perivoliotis, Dimitri Perivoliotis, Kayla Knopp, Kayla Knopp, Shannon Remick, Allie Kaigle, Allie Kaigle, Christopher S. Stauffer, Christopher S. Stauffer, Chandra Khalifian, Chandra Khalifian, Tamara R. Wachsman, Bettye E. Chargin, Andrew W. Bismark, Andrew W. Bismark, Al Alam, Al Alam, Leslie Morland, Leslie Morland, Leslie Morland

    Published 2025-01-01
    “…MDMA-assisted therapy (MDMA-AT) for PTSD is a promising intervention currently being evaluated in numerous studies worldwide, including investigation for potential Food and Drug Administration (FDA) approval in the United States. …”
    Get full text
    Article
  20. 120